Dailyglim PM 2 (Glimperide Pioglitazone & Metformin Hydrochloride (Extended release) (2mg/15mg/500mg))

Dailyglim PM 2 is a combination of Glimperide 2 mg Pioglitazone 15 mg and Metformin Hydrochloride 500 mg (Extended Release). This medicine is used to manage type 2 diabetes mellitus by enhancing the body’s ability to use insulin effectively. Glimperide stimulates insulin release from the pancreas Pioglitazone improves insulin sensitivity and Metformin reduces glucose production in the liver. Together they help in achieving better blood sugar control.